SwitzerlandOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 4,179 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 109,295 | 112,673 |
| Total Cites | 10,543 | 11,510 |
| H-index | 46 | 48 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 44 | 54 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 2,371 | 2,564 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 3,470 | 3,826 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,364 | 8,922 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
8.40%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 4,027 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103,574 | 105,266 |
| Total Cites | 10,238 | 11,191 |
| H-index | 45 | 48 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 43 | 53 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 2,342 | 2,534 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 3,381 | 3,733 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,130 | 8,683 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
8.52%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 4,046 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102,916 | 106,093 |
| Total Cites | 9,738 | 10,605 |
| H-index | 42 | 44 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 43 | 53 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 2,320 | 2,509 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 3,224 | 3,561 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,756 | 8,246 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
8.18%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 3,559 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89,057 | 93,977 |
| Total Cites | 9,590 | 10,508 |
| H-index | 43 | 44 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 43 | 53 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 2,285 | 2,474 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 3,195 | 3,529 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,600 | 8,147 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
8.74%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.